In summary, anomalous MEK-dependent ERK1/2 activation in SSRBCs can contribute to the pathogenesis of SCD by potentially activating at least two significant cellular players of vasoocclusive events, SSRBC adhesion and SSRBC-induced activation of leukocytes. Here, MAP2K7 is linked to Schnyder corneal dystrophy.